logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study by Prof Bruno Sangro PhD & Prof Masatoshi Kudo PhD & Prof Joseph P Erinjeri PhD & Prof Shukui Qin MD & Prof Zhenggang Ren MD & Prof Stephen L Chan MD & Yasuaki Arai MD & Prof Jeong Heo PhD & Anh Mai MD & Jose Escobar MD & Yamil Alonso Lopez Chuken MBBS &... instant download

  • SKU: EBN-239571688
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

4.8

28 reviews
Instant download (eBook) Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study after payment.
Authors:Prof Bruno Sangro PhD & Prof Masatoshi Kudo PhD & Prof Joseph P Erinjeri PhD & Prof Shukui Qin MD & Prof Zhenggang Ren MD & Prof Stephen L Chan MD & Yasuaki Arai MD & Prof Jeong Heo PhD & Anh Mai MD & Jose Escobar MD & Yamil Alonso Lopez Chuken MBBS &...
Pages:updating ...
Year:2025
Publisher:x
Language:english
File Size:1.36 MB
Format:pdf
Categories: Ebooks

Product desciption

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study by Prof Bruno Sangro PhD & Prof Masatoshi Kudo PhD & Prof Joseph P Erinjeri PhD & Prof Shukui Qin MD & Prof Zhenggang Ren MD & Prof Stephen L Chan MD & Yasuaki Arai MD & Prof Jeong Heo PhD & Anh Mai MD & Jose Escobar MD & Yamil Alonso Lopez Chuken MBBS &... instant download

The Lancet, 405 (2025) 216-232. doi:10.1016/S0140-6736(24)02551-0
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products